methods of treating, preventing or controlling a myelodysplastic syndrome, reducing or preventing an adverse effect associated with the administration of a second active ingredient in a patient suffering from a myelodysplastic syndrome, pharmaceutical composition, single unit dosage form, and kit

摘要

"METHODS OF TREATMENT, PREVENTION OR CONTROL OF A MYELODISPLASTIC SYNDROME, REDUCING OR AVOIDING AN ADVERSE EFFECT ASSOCIATED WITH ADMINISTRATION OF AN ACTIVE INGREDIENT SYNDROME, PATIENT UNIFIED SYNDROME, PATIENTS Methods of treatment, prevention, and / or control of myelodysplastic syndromes are described. Specific methods include administering an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate or prodrug thereof, alone or in combination with a second active ingredient, and / or transplanting blood or cells. . The second specific active compounds are capable of affecting blood cell production. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also described.